Additionally, there are reports indicating that the inhibition of MMP-2 and 9 activation may occur through the inhibition of the RhoA/ROCK pathway, but this issue has not yet been widely studied in heart diseases, although metalloproteinases play an important role in their pathomechanism. The gene discussed is RHOA; the disease is heart disorder.